Filing Details
- Accession Number:
- 0001209191-12-014712
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-01 19:33:39
- Reporting Period:
- 2012-02-28
- Filing Date:
- 2012-03-01
- Accepted Time:
- 2012-03-01 19:33:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411861 | Mako Surgical Corp. | MAKO | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 201901148 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1424202 | Morry S Blumenfeld | 2555 Davie Road Fort Lauderdale FL 33317 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-28 | 24,665 | $40.03 | 532,283 | No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Common Stock | Disposition | 2012-02-29 | 7,500 | $40.00 | 524,783 | No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ziegler Meditech Equity Partners, L.P. on November 11, 2011.
- The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.10 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownerhsip of the shares except to the extent of his pecuniary interest therein.